Wednesday, October 26, 2022 at 2pm EDT|11am PDT|7pm BST|8pm CEST In this webinar, we will we review case studies of successful thought leader engagement plans across the product launch continuum to address the complexity including establishing a modeling framework early, incorporating thought leader behavior profiles and peer recognition data in addition to key milestone for creating the most efficient plan possible.
Register Free: https://www.pharmexec.com/pe_w/thought_leader
Event Overview:
Best practices are emerging to address the complexity of thought leader segmentation of external stakeholder attribute needs along the launch continuum. Thought leader segmentation models should evolve at each stage of launch to align with cross-functional needs, and this becomes more difficult with significant advances in accessible data sources and technology options where prioritization is critical.
In this webinar, we will review case studies of successful thought leader engagement plans across the product launch continuum to address the complexity. This includes establishing a modeling framework early, incorporating thought leader behavior profiles and peer recognition data in addition to key milestones for creating the most efficient plan possible.
Three Key Take-aways
Speakers
Linda Traylor PhD
Sr. Principal, Medical Affairs
IQVIA
Linda has 25 years of experience in clinical research and medical affairs across the life sciences industry, including small and large pharma, medical devices, biologics, and diagnostics with extensive cross-functional support. Her career spans multiple therapeutic areas, including oncology, immunology, infectious disease, diabetes, cardiovascular, kidney disease, and precision medicine. Linda has expertise in solving complex medical affairs challenges and developing data-driven narratives to support clinical research and product adoption.
Darin DeCarlo
Practice Lead, Thought Leader Center of Excellence
IQVIA
Darin DeCarlo is the Practice Lead for IQVIA’s Thought Leader Center of Excellence, and a Senior Principal of Launch Advisory Services. His team specializes in identification of key opinion leaders and HCP network science. He has over 25 years of industry experience, including leadership positions in marketing, sales, market access, and commercial operations for both large pharma and biotechnology startups.
Rina Patel, MD
Director of Medical Affairs, Strategy and Development
IQVIA
Rina has more than 10 years of experience in clinical, academia, and the pharmaceutical industry. She has experience in a variety of therapeutic areas and works cross functionally to support the medical strategy. She leads and drives the implementation of the strategic vision, direction, and deployment of the Field Medical Affairs teams.
Register Free: https://www.pharmexec.com/pe_w/thought_leader
Streamlining the Path to Market for Novel Therapies: 5 Strategies for Success
October 15th 2021While advanced therapy medicinal products (ATMPs) hold great promise, the path to exploiting the technology has been challenging. Christian K. Schneider outlines the five strategies that must be considered to increase the success rates of development programs, while avoiding some of the common pitfalls.